The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 27, 2015

Filed:

Oct. 16, 2012
Applicants:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare S.a., Glattpark (Opfikon), CH;

Inventors:

Leopold Bruckschwaiger, Vienna, AT;

Sonja Svatos, Berg, AT;

Julia Nuernberger, Vienna, AT;

Wolfgang Teschner, Vienna, AT;

Harald Arno Butterweck, Vienna, AT;

Hans-Peter Schwarz, Vienna, AT;

Thomas Gundinger, Vienna, AT;

Bernhard Koelbl, Achau, AT;

Reinhard Grausenburger, Vienna, AT;

Azra Pljevljakovic, Vienna, AT;

Assignees:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark (Opfikon), CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A23J 1/00 (2006.01); C07K 1/00 (2006.01); C07K 14/16 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); C07K 1/36 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 35/16 (2006.01); A61K 47/18 (2006.01); C07K 1/30 (2006.01); C07K 16/06 (2006.01); A61K 38/17 (2006.01); C07K 1/14 (2006.01); C07K 1/34 (2006.01); C07K 1/18 (2006.01);
U.S. Cl.
CPC ...
C07K 1/36 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 35/16 (2013.01); A61K 47/183 (2013.01); C07K 1/30 (2013.01); C07K 16/065 (2013.01); A61K 38/1709 (2013.01); C07K 1/14 (2013.01); C07K 1/34 (2013.01); C07K 1/18 (2013.01);
Abstract

The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein.


Find Patent Forward Citations

Loading…